Table 2. Clinical trials in the gene therapy of osteoarthritis.
Transgene | Vector Ex/In Vivo |
Phase | PI, Institution or Sponsor |
OBA Protocol Number |
Status | Number of subjects |
---|---|---|---|---|---|---|
TGF-β1 | Retrovirus Ex Vivo |
I | Ha, Kolon Life Sciences, Korea |
NA | Closed | 12 |
TGF-β1 | Retrovirus Ex Vivo |
I | Mont TissueGene Inc |
0307-594 | Closed | 9 |
TGF-β1 | Retrovirus Ex Vivo |
IIa | Ha, Kolon Life Sciences, Korea |
NA | Recruitment Complete |
28 |
TGF-β1 | Retrovirus Ex Vivo |
II | Mont TissueGene Inc |
0912-1016 | Open | 100 |
OBA : Office of Biotechnology Activities
N = number of subjects in study
NA = Not Applicable